NDC 0485-0208

ED BRON GP

Guaifenesin And Phenylephrine

ED BRON GP is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Edwards Pharmaceuticals, Inc.. The primary component is Guaifenesin; Phenylephrine Hydrochloride.

Product ID0485-0208_43f06e29-011d-4c45-96a2-c15fa4d90bac
NDC0485-0208
Product TypeHuman Otc Drug
Proprietary NameED BRON GP
Generic NameGuaifenesin And Phenylephrine
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2012-06-01
Marketing CategoryOTC MONOGRAPH FINAL / UNAPPROVED DRUG OTHER
Application Numberpart341
Labeler NameEDWARDS PHARMACEUTICALS, INC.
Substance NameGUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Active Ingredient Strength100 mg/5mL; mg/5mL
Pharm ClassesAdrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0485-0208-16

473 mL in 1 BOTTLE, PLASTIC (0485-0208-16)
Marketing Start Date2012-06-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0485-0208-16 [00485020816]

ED BRON GP LIQUID
Marketing Categoryunapproved drug other
Product TypeHUMAN OTC DRUG
Billing UnitML
Marketing Start Date2012-06-01

Drug Details

Active Ingredients

IngredientStrength
GUAIFENESIN100 mg/5mL

OpenFDA Data

SPL SET ID:b1fca5aa-d877-45e0-b074-dcbc6af94ee3
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1358627

  • Trademark Results [ED BRON GP]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ED BRON GP
    ED BRON GP
    86330989 4682161 Live/Registered
    Edwards Pharmaceuticals, Inc.
    2014-07-08

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.